Diabetes Q&A: 70/30; "Rule of Fifths"; Split-Mix; Basal-Bolus-- Which Is Best?

Publication
Article
Consultant for PediatriciansConsultant for Pediatricians Vol 6 No 2
Volume 6
Issue 2

During my training, most pediatric endocrinologists were using the "70/30 rule" or the "rule of fifths" to determine the insulin dosage for patients with new-onset diabetes. Now that I am in practice, I have heard that carbohydrate counting is a more accurate method of determining a child's insulin needs.

Q: During my training, most pediatric endocrinologists were using the "70/30 rule" or the "rule of fifths" to determine the insulin dosage for patients with new-onset diabetes. Now that I am in practice, I have heard that carbohydrate counting is a more accurate method of determining a child's insulin needs.

Is carbohydrate counting, in fact, a better approach to determining the insulin dosage for a patient with newly diagnosed diabetes? If so, how is this done for both regular and long-acting insulin? Do age and weight play a role?

A: There is no one "right"method for determining the appropriate initial insulin dosage for children with new-onset type 1 diabetes (T1D). Choosing an insulin regimen often involves a trade-off between accuracy and simplicity.

The split-mix regimen. Until recently, most pediatric patients with T1D were started on a "2-shot split-mix" regimen, which combined short- and long-acting insulins in a single injection given twice daily at a total daily dose of approximately 1 unit/kg. Typically, two thirds of the total daily dose was given at breakfast and one third before dinner. Two thirds of the morning dose was given as long-acting insulin (such as NPH or Lente) and one third as short-acting (such as Regular or one of the rapid-acting analogs). Half of the evening dose was given as long-acting and half as short-acting insulin. For example, for a child who weighs 36 kg, the initial insulin doses would be 8 lispro/aspart plus 16 NPH at breakfast and 6 lispro/aspart plus 6 NPH at dinner.

Many clinicians are now moving away from the 2-shot split-mix regimens because they are usually insufficient to meet intensive glycemic goals without unacceptable swings in blood sugar levels. Three-shot regimens move the dinner NPH dose to bedtime to provide better overnight coverage. Extra "touch-up" doses of short-acting insulin are often needed at lunch or in the midafternoon. The split-mix regimen does require consistency and regularity in meal portions and timing.

The "basal-bolus" method. With the development of once-daily long-acting insulin analogs (glargine and detemir), many clinicians have completely abandoned the split-mix regimen in favor of the basal-bolus method. This more physiologic insulin replacement strategy uses a single dose of a long-acting "basal" insulin to provide background insulin coverage, plus "bolus" doses of rapid-acting insulin analogs for every meal and snack. This method does require that the patient and/or caregiver have some knowledge of carbohydrate counting:

•Infants and toddlers may require 1 unit of rapid-acting insulin for every 20 to 50 g of carbohydrate.

•Preadolescents may require 1 unit per 10 to 20 g.

•Adolescents may require 1 unit per 5 to 10 g.

Alternatively, the insulin-to-carbohydrate ratio (ICR) may be determined by the "450 rule." To determine the ICR, divide 450 by the child's total daily dose of insulin (TDD). For example, for a child with a TDD of 36 units, the ICR would be 450/36 = 12.5, or 1 unit per 12 g of carbohydrate. The basal-bolus strategy allows more freedom in the amounts and timing of meals.

As always, the "best" method for determining insulin dosing should take into account a realistic assessment of the family's and child's abilities and life situation. Many older children and adolescents will tolerate 4 or 5 injections per day for flexibility in meal content and timing. Younger children typically prefer to eat consistently and have fewer shots.

Generally, we still use a 2-shot regimen during the first several months after diagnosis, while patients still have some residual insulin secretion (the "honeymoon period"). After the honeymoon--when blood sugar levels cannot be controlled adequately with 3 shots daily--we make the transition to basal-bolus therapy. This involves either multiple daily injection therapy using glargine or detemir plus aspart or lispro, or continuous subcutaneous insulin therapy (the pump).

Recent Videos
Linda DiMeglio, MD, MPH
Related Content
© 2024 MJH Life Sciences

All rights reserved.